1. First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study. Issue 3 (29th December 2020) Authors: Laude, Marie‐Charlotte; Lebras, Laure; Sesques, Pierre; Ghesquieres, Herve; Favre, Simon; Bouabdallah, Krimo; Croizier, Carolyne; Guieze, Romain; Drieu La Rochelle, Laurianne; Gyan, Emmanuel; Chin, Roza; Aurran‐Schleinitz, Thérèse; Marouf, Amira; Deau‐Fischer, Bénédicte; Coppo, Paul; Malot, Sandr... Journal: American journal of hematology Issue: Volume 96:Issue 3(2021) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group. Issue 11 (November 2020) Authors: Le Gouill, Steven; Beldi-Ferchiou, Asma; Alcantara, Marion; Cacheux, Victoria; Safar, Violaine; Burroni, Barbara; Guidez, Stéphanie; Gastinne, Thomas; Canioni, Danielle; Thieblemont, Catherine; Maisonneuve, Hervé; Bodet-Milin, Caroline; Houot, Roch; Oberic, Lucie; Bouabdallah, Krimo; Bescond, Cha... Journal: Lancet Issue: Volume 7:Issue 11(2020) Page Start: e798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗